Eventide Asset Management, LLC Edwards Lifesciences Corp Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $190,375 - $239,889	-3,085 Reduced 31.5%	6,709 $511,000
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $324,646 - $437,578	4,686 Added 91.74%	9,794 $678,000
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $87,759 - $101,687	1,078 Added 26.75%	5,108 $481,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $105,671 - $120,257	1,423 Added 54.58%	4,030 $333,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $178,058 - $227,956	2,607 New	2,607 $194,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.